Top Stories News
Top Stories news
-
News India to Further Strengthen Collaboration with Japan in Pharma Business
Pharmexcil hopes to get IJPA's assistance in getting appropriate inputs on regulatory requirements and market dynamics in Japan. -
News AstraZeneca to Acquire Ardea Biosciences And Lead Product Lesinurad
AstraZeneca is acquiring San Diego-based Ardea for $32 per share. -
News University-industry Partnerships Declined in 2011, ABPI Survey Finds
An ABPI report has highlighted the importance of partnerships between universities and pharmaceutical companies and called for greater collaboration to maintain the UK's leadership in medical research. -
News XTL Biopharmaceuticals Reveals Plans to Acquire Drug Development Company
XTL Biopharmaceuticals, a public company traded on the Tel Aviv Stock Exchange, has announced that it has signed a non-binding letter of intent to acquire a drug development company. -
News Express Scripts Solution to Address Medication Non-adherence
An innovative new solution could help to tackle the major problem of medication non-adherence. -
News Takeda Announces URL Pharma Acquisition
Takeda is enhancing its gout treatment portfolio with the acquisition of URL Pharma. -
News GE Healthcare Teams up with Clino to Accelerate Alzheimer's Research
GE Healthcare and Clino Ltd have announced a joint research project with a view to developing new diagnostic solutions for Alzheimer's disease. -
News AMRI Announces Deal with Biota
AMRIs role will initially involve the development and manufacture of the active pharmaceutical ingredient for use in clinical trials. -
News Amgen to Acquire KAI Pharmaceuticals in $315M Deal
KAI Pharmaceuticals is to become a wholly owned subsidiary of Amgen. -
News Humira Receives EU Approval for Ulcerative Colitis
Abbot's biologic therapy Humira has now received EU approval for the treatment of adult patients with ulcerative colitis. -
News Shire Announces Top-line Results of Prevent2 Phase-III Trial of MMX Mesalamine
Shire has revealed that it does not plan to pursue a regulatory filing for MMX mesalamine in patients with a history of diverticulitis, after the drug failed to meet the primary endpoint in a recent phase-III study. -
News Merck Announces Publication of Phase-III Data for Shingles Vaccine Zostavax
Efficacy and safety data that supported the US FDA's expanded indication for Zostavax in 2011 have been published in Clinical Infectious Diseases. -
News Catalent & BASF Form Bioavailability Alliance
The companies will combine their expertise to provide a range of services to address pipeline challenges with BCS Class II and IV poorly bioavailable compounds. -
News Lonza Names New CEO
Richard Ridinger has been named chief executive officer of Lonza and will take over the role on May 1. -
News Charles River & Metabolon Ink Biomarker Pact
The cooperation combines Charles Rivers preclinical oncology study expertise with Metabolons analysis of metabolic data to identify both mechanism of action and biomarkers. -
News AKESOgen & London Genetics International Form Alliance
The two firms will collaborate to help biopharma companies take advantage of pharmacogenetic solutions, including novel biomarker and assay development services. -
News Sinovac Biotech Announces Director Appointment
Sinovac Biotech has announced the appointment of Mr. Meng Mei as an independent director. The appointment enables Sinovac to comply with NASDAQ Listing Rule 5605 requirement. -
News Almac & Affymetrix Ink Distribution Pact
Almac has entered into an agreement with Affymetrix for Xcel Array distribution. -
News SCM Pharma Wins Science & Technology Award
SCM Pharma was named the winner of the Science & Technology Award at the North East Business Award for the UKs Northumberland and Tyneside region. -
News Seaside Therapeutics Obtains Patent for Autism Drug Candidate STX209
Seaside Therapeutics has obtained a US patent covering its lead product candidate STX209 for the improvement of social and communication functions in autism spectrum disorders. -
News Bayer HealthCare & Tsinghua Expand Drug Discovery Pact
Scientists from Tsinghua University will work with Bayer scientists to solve the 3D protein structure of biological molecular targets as a basis for new drug discovery projects. -
News Impax & Tolmar Ink Supply Pact
The two firms have signed a multi-product deal for the development, supply and distribution of alternative dosage form products. -
News Novasep Opens New Facility in China
Novasep will expand purification process solutions for biopharmaceuticals including recombinant proteins, peptides and biosimilars, including monoclonal antibodies and insulin, and pharmaceuticals such as optical isomers and certain anti-cancer APIs. -
News Roche Once Again Extends Illumina Bid
The hostile approach, which is valued at approximately $5.7bn, will now give shareholders until April 20 to accept an offer of $44.50 per share. -
News Daiichi Sankyo Announces New Global Corporate Slogan
The new slogan 'Passion for Innovation. Compassion for Patients.' will be rolled from April 1, 2012 via corporate advertisements, corporate websites and so on. -
News Anaphore Acquires RuiYi in China
The acquisition of RuiYi allows Anaphore to access the substantial scientific expertise, capital and potential new collaboration opportunities in the Chinese pharmaceutical marketplace. -
News Ablynx Extends Nanobody Pact with BI
Ablynx has extended nanobody alliance with Boehringer Ingelheim. -
News UCB Pharma with Oxford University to Develop Drugs for Serious Diseases
UCB will fund the collaboration with ?3.6 million over three years to develop medicines that will treat serious diseases in immunology and neurology. -
News Abbott Announces Name for New Drug Company
The name for its new research-based pharmaceutical company is derived from a combination of Abbott and 'vie,' which references the Latin root 'vi' meaning life. -
News Astellas Withdraws Application for Extension of Qutenza Indication
The company stated that it decided to withdraw the application based on the CHMP's view that the data provided do not allow the Committee to conclude on a positive benefit-risk balance. -
News Eisai Expands Business in EMEA Region
The new expansion in the European, Middle Eastern and African markets is part of the company's plan to have a presence in the top 20 pharmaceutical market regions by 2015. -
News Shire Licenses CNS Drug
Heptares will receive an upfront option grant and exercise payments and is eligible to receive future development and commercial milestone payments of as much as $190 million, plus royalties on sales. -
News SanBio Starts Enrollment in Clinical Trial of Stem Cell Therapy for Chronic Stroke
The stem cell therapy SB623 is derived from adult bone marrow and has shown safety and efficacy in rodent models of chronic stroke. -
News Health Canada Facilitates Review Process to Ease Drug Shortage
It usually takes around six months to complete an assessment and approve a drug for use in Canada. However, Health Canada is speeding up its drug review process to ease the drug shortage. -
News Sigma-Aldrich Opens New Facility in China
The new facility will provide localized packaging, analytical services and quality control for high-quality products to support the Company's research and industrial customers in the region. -
News Sanofi to Close Manufacturing Plant in Newcastle
The move comes as the company is forced to contend with European health spending cuts and generic competition to Plavix, the top-selling blood thinner, which is manufactured at the site. -
News Bayer Sets Ambitious Targets for 2014
Sales of Bayer HealthCare are expected to reach approximately EUR 20 billion in 2014, while Bayer CropScience aims to raise sales to more than EUR 8 billion. -
News CPHI Worldwide to Return to Frankfurt in 2013
UBM has announced that CPHI Worldwide, ICSE, P-MEC Europe and InnoPack will return to Frankfurt, Germany from 22nd to 24th October 2013. The events will run this year from 9th to 11th October in Madrid and had a record breaking year at the Messe Frankf... -
News Biocon & Pfizer End Biosimilar Partnership
Biocon and Pfizer have ended their biosimilar insulin alliance. All rights licensed to Pfizer will now be transferred back to Biocon. -
News DSM & Agennix Sign New Contract for Talactoferrin
DSM Pharmaceutical Products and Agennix AG have signed a new contract under which DSM will manufacture the oral Dendritic Cell Mediated Immunotherapy talactoferrin for Agennix at commercial levels. -
News Hovione Appoints VP of Particle Design Unit
Dr. Colin Minchom will serve as vice president of Hovione's Particle Design Business Unit. -
News Particle Sciences Acquires LyoCell Technology
Particle Sciences will offer the technology to clients looking to increase bioavailability or develop parenteral formulations of difficult-to-solubilize compounds. -
News India's Delegation Completes Inspection of Chinese Manufacturing Facilities
During the visit to China from February 11 to 22, the team of the CDSCO inspected three API units and one diagnostics units. -
News GSK Launches Apprenticeship Scheme in UK
Apprenticeships will last between 24 years depending on the discipline. All roles will be a combination of on-the-job training and studying. -
News Antifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth
The report from GBI Research examines the global antifungal therapies, treatment usage patterns and treatment flow algorithm. It also analyzes the geographical distribution of antifungal therapies across the US, the top five countries in the European r... -
News WuXi PharmaTech Announces Q4 2011 Results
The leading contract research outsourcing provider's fourth-quarter 2011 net revenues increased 22.5% year over year to $108.5 million. -
News CPHI Japan Returns to Tokyo for 2012
As the largest pharma ingredients event in the country, CPHI Japan provides an invaluable opportunity to meet in person and continue to build relationships, whether existing or new. -
News SK Bio-Pharmaceuticals Announces New CEO
SK Biopharmaceuticals announced that Christopher Gallen, M.D., Ph.D., has joined the company as its new CEO as of March 1. -
News GE Healthcare to Acquire Xcellerex
The acquisition of Xcellerex will allow GE Healthcare to expand its offering of products and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines. -
News Luye Pharma Obtains Exclusive License of New Antidiabetic Preparation in China from Dong-A Phama
Dong-A authorizes the exclusive right of DA-1229 to Luye which will be responsible for self-development, reporting and sales of the products raw materials and preparation in China. -
News Medicago Forms Alliance with Mitsubishi Tanabe Pharma for Rotavirus Vaccines Development
Canada's Medicago and Osaka-based Mitsubishi Tanabe Pharma have formed a strategic alliance to develop three new rotavirus vaccines. -
News Prometrika & Medidata Form Strategic Partnership
Prometrika has selected Medidata Solutions as a strategic partner to increase sponsor access to its range of clinical research services. -
News Catalent Completes Acquisition of R.P. Scherer Eberbach
Catalent Pharma Solutions has completed its acquisition of R.P. Scherer Eberbach, gaining the remaining 49% interest from Gelita AG. -
News Thrombotech Receives IND Approval from FDA
Thrombotech Ltd. has received an IND approval from the FDA enabling the initiation of a Phase IIa clinical trial in the U.S. -
News GSK & Daiichi Sankyo to Form Vax JV in Japan
The JV will supply globally recommended vaccines in Japan, including Human Papillomavirus (HPV) vaccine, Rotavirus, Seasonal flu, Mumps, Diphtheria Pertussis (DTP), and Measles Rubella (MR) vaccines. -
News Abbott & Galapagos Announce Collaboration for Arthritis Drug
Abbott Laboratories has made a development agreement with Galapagos for a mid-stage rheumatoid arthritis medication. -
News GSK Partners with Angiochem for LSD Treatments
The partnership will work on the creation of new compounds capable of restoring function in the central nervous system. -
News Merck Millipore Opens Lab Water Production Facility in China
The site will manufacture the Ming Che series of tailor-made lab water purification systems and consumables, which will be sold exclusively in China. -
News Celerion & Ricerca Form Biosimilars Alliance
The alliance will offer access to all of the services required to perform early assessment of the viability of a potential biosimilar product before initiating multi-center comparator studies in the target patient populations. -
News Sanofi & the Institut Pasteur Create Awards to Encourage Research
Sanofi and the Institut Pasteur has announced the creation of the Sanofi-Institut Pasteur Awards to encourage scientific excellence in the service of health. -
News Penn Pharma to Invest $22M in UK Facility
Penn Pharma will invest $22 million in its UK facility to strengthen its manufacturing capabilities. -
News Angiochem & GSK Ink Development Pact
The collaboration will combine Angiochem's expertise in creating novel therapeutics that cross the blood-brain barrier (BBB) with the scientific, development and commercialization capability of GSK in rare diseases. -
News Haupt Pharma & Fraunhofer Institute Ink Supply Chain Pact
The alliance aims to boost the efficiency, quality and monitoring of the supply chain processes as part of a continuous optimization process, as well as increase economic efficiency through the reduction of reject quantities. -
News Pfizer Announces Acquisition of Alacer
California-based Alacer is well-known among health-conscious consumers as a provider of Vitamin C supplement products. It produces almost 500 million packets of Emergen-C annually. -
News Quintiles Teams up with Russian Investment Firm to Expand Clinical Development Services
Quintiles is extending its footprint in Russia by teaming up with a Russian-based investment firm. -
News Hospira Joins the Generic Pharmaceutical Association
Hospira has announced its membership of the Generic Pharmaceutical Association (GPhA). -
News BASF Announces Record Increase in Sales
BASF posted the fourth-quarter results last Friday and reported a record increase in sales which rose to 73.5bn in 2011. -
News Merck Announces Efficiency Program
The planned efficiency measures are part of the Groups comprehensive transformation program. -
News Lanthio Grants Tarix Exclusive License to Agonistic Peptide
Lanthio Pharma has granted Tarix Pharmaceuticals an exclusive license to its lanthionine-stabilized Angiotensin-(1-7) agonistic peptide for the treatment of acute lung injury. -
News Auxilium & Actelion Enter Agreement for Xiaflex
Actelion will pay Auxilium $10 million upfront and will also make up to $16 million in potential regulatory, pricing, and reimbursement milestone payments and $42.5 million in potential sales milestone payments. -
News Dako Forms Diagnostic Alliance with Amgen
Dako announced a new collaboration agreement with Amgen on the development of a diagnostic test for an Amgen cancer drug candidate in clinical development. -
News Bactiguard & Cadila Sign Distribution Agreement
Cadila Pharmaceuticals will sell the entire line of Bactiguard?s products throughout India. -
News Boehringer Ingelheim & Xencor Ink Biosuperiors Pact
Xencor and Boehringer Ingelheim have entered into a new alliance on the development of new biosuperior monoclonal antibodies. -
News Enanta Signs License Agreement with Novartis
Novartis will be responsible for all costs associated with the development, manufacture and commercialization of EDP-239 and will fund Enanta's drug discovery efforts on certain additional compounds targeting NS5A. -
News Sigma Life Science Obtains Global License for Kyoto University's iPS Cell Patent Portfolio
Sigma Life Science has acquired a worldwide license to use Kyoto University's induced pluripotent stem (iPS) cell patent portfolio. -
News Johnson & Johnson Names Alex Gorsky CEO Effective April 26, 2012
Mr. Gorsky succeeds Bill Weldon, who has served as Chairman and CEO of Johnson & Johnson since 2002. -
News DPT Laboratories Appoints R&D VP
Dr. Bhatia will lead the research and pharmaceutical development group and oversee DPT's Center of Excellence for R&D in San Antonio. -
News Brenntag Launches New Head Office in India
The German chemicals distributor's new head office will provide room for the firms planned growth in India over the next few years. -
News Pfizer Considers $3Bn Partial IPO
Pfizer is said to raise about $3bn this year through a part-flotation of its animal health division. -
News 18% Growth in Sales Accelerates Investment and Expansion Plans for Robinson Brothers and Endeavour
UKs independent chemical manufacturer Robinson Brothers Limited announced a significant rise in group sales for 2011. -
News Endeavour Speciality Chemicals Enters Partnership with AKL Research
Under the agreement Endeavour will act as the sole scale-up partner for the AKL range of building blocks and chemical intermediates, many of which are commercially novel. -
News Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals
Par Pharmaceutical has completed the acquisition of India-based Edict Pharmaceuticals, a developer and manufacturer of generic pharmaceuticals with 11 ANDAs filed with the FDA. -
News Evotec & IR Pharma Ink Respiratory Discovery Pact
Under the alliance, Evotec will offer fully integrated respiratory and inflammation focused drug discovery programs, from target to nomination of preclinical development candidates. -
News Actavis Launches Donepezil in Eight EU Markets
The conventional tablets were launched in Germany, France, Italy, Spain, the UK, Denmark, Sweden and Austria this week. -
News GSK Withdraws Application for Tyverb Indication Extension
The decision to withdraw the application was based on the CHMPs assessment that the lack of an active-controlled trial hampers the proper assessment of the benefit-risk balance in European patients in the applied indication. -
News BARDA Awards Tetraphase Antibiotic Contract
The BARDA contract includes preclinical efficacy and toxicology studies, clinical studies, manufacturing, and associated regulatory activities for TP-434. -
News Sigma-Aldrich Completes Acquisition of BioReliance
The acquisition will leverage SAFCs industrial media presence and BioReliances biological testing services. -
News Endeavour Speciality Chemicals Announces Novel Thiourea Line
Endeavour Speciality Chemicals has announced the introduction of a line of commercially novel pyridinyl thioureas to be used as building blocks in the research of treatments for prion diseases. -
News FDA Seeks $4.5B in 2013 Budget
In addition to recommending new user fees to support the review of generic drugs and biosimilars, the FDA budget also contains increased funding ($1.7bn) to improve the safety of drugs and other medical products, advance medical countermeasures and fac... -
News Merck & Supera Farma Form Brazilian JV
The new JV will market, distribute and sell a portfolio of innovative pharmaceutical and branded generic products from Merck, Cristália and Eurofarma solely in the Brazilian retail sector. -
News Asymchem Laboratories Announces Introduction of New Manufacturing Facility
The facility was built to meet an annual demand for commercial projects > 5 MT and will serve to expand Asymchem's capabilities in high volume processing and back-end ingredient and intermediate production. -
News Biogen Idec to Acquire Stromedix
Biogen Idec will make an upfront cash payment of $75 million and additional contingent value payments of up to $487.5 million based on the achievement of certain development and approval milestones across multiple indications. -
News Ockham Completes Acquisition of Nexus Oncology
This merger offers an enhanced global scale, a depth of oncology-specific therapeutic expertise and new levels of operational excellence. -
News BMS Completes Acquisition of Inhibitex
Bristol-Myers Squibb has announced the successful completion of the tender offer by Bristol-Myers Squibb Company for all of the outstanding shares of common stock of Inhibitex, Inc. -
News Particle Sciences Collaborates with Chemo
Under the agreement, the two companies will leverage each others strengths to provide a start to finish contract solution for those looking to develop and market hormone eluting devices. -
News Bosch Packaging Technology to Acquire Eisai's Machinery Business
Bosch Packaging Technology is to acquire Eisais machinery business to strengthen its position in the pharmaceutical market. -
News Elan Reports Fourth Quarter and Full-Year 2011 Results
Total revenue for the full-year 2011 increased by 19% to $1,068.1 million, from $895.6 million for the full-year 2010. -
News Bend Research Licenses Spray-dried Dispersion Tech to Lilly
This technology is designed to improve the bioavailability of compounds with low aqueous solubility and has been applied to hundreds of compounds at various stages of development. -
News Promega develops new assay to test cytotoxicity levels
Promega Corporation says its new assay is more flexible than alternatives. -
News PAREXEL Expands Global Clinical Logistics Services
The new facilities expand on the companys existing clinical logistics infrastructure throughout North America, Latin America, Europe, Africa and the Asia/Pacific region. -
News Illumina Rejects Roche's Unsolicited Tender Offer
Illumina's Board of Directors determined that the $44.50 per share cash offer is grossly inadequate in multiple respects, dramatically undervalues Illumina and is contrary to the best interests of Illumina's stockholders. -
News GlaxoSmithKline Reports Full Year Results 2011
The underlying pharmaceuticals growth came from new products, partly offset by generic competition to older products in the US and Europe and the increased impact of European austerity measures. -
News Merck Serono Inks Licensing Deal with Threshold Pharmaceuticals for Cancer Drug
Merck will obtain co-development and exclusive global commercialisation rights, whilst Threshold will retain the option to co-commercialise TH-302 in the US. -
News GSK to Expand Manufacturing Capacity at Australian Plant
GlaxoSmithKline will invest A$60m to expand its manufacturing and new drug development activities in Australia. -
News Melbourn Scientific Appoints Operations Director
UK's Melbourn Scientific has appointed laboratory manager, Derek Solomon, as operations director. -
News Syntagon Announces Addition of Quality Assurance Expert
Syntagon announced that George K?llner, a Quality Assurance expert, has joined the company. -
News Swiss RohnerChem Forms Partnership with German Evocatal
RohnerChem and evocatal have announced partnership for enzymatic chemistry development and upscaling. -
News OctoPlus and Ferring Ink Drug Development Deal
OctoPlus N.V. has signed a formulation development and manufacturing contract with Ferring Pharmaceuticals. -
News SCM Pharma to Deliver Vial Filling Project
SCM Pharma is to develop and manufacture an injectable neonatal product for BrePco BioPharma. -
News Catalent Completes Facility Expansion in Italy
Catalent Pharma Solutions announces the completion of the expansion of its facility in Aprilia, Italy. -
News Almac Launches Next Generation Sequencing Data Analysis Services
The services include professional study design to sample processing and expert data analysis for DNA and RNA samples. -
News PAREXEL Enters Alliance with ASAN Medical Center
The alliance offers regional and international sponsors with access to quality clinical trial services throughout Asia. -
News Diabetes Drug Bydureon Wins FDA Approval
Amylin's Bydureon diabetes drug has won approval from US regulators. -
News NIH Joins Clinical Trial of New Tuberculosis Vaccine
This is the first time that NIH is leveraging its HIV/AIDS clinical trial networks to advance a tuberculosis vaccine candidate. -
News India & Japan to Sign Protocol to Boost Pharma Trade during CPHI Japan 2012
India and Japan are likely to sign a protocol to boost their pharmaceuticals trade. -
News DSM Inks Pact with Indoco for APIs
In line with DSM and Indoco's strategy, the agreement represents a step to forge an alliance to expand presence in markets across the globe. -
News Valeant Withdraws Bid for ISTA Acquisition
Valeant Pharmaceuticals announced Monday that the company has withdrawn its offer to acquire ISTA Pharmaceuticals. -
News Sartorius Stedim Biotech & Refine Technology to Jointly Develop Cell Cultivation Platform
This joint development project proactively responds to the current market demand for more effective connectivity between equipment from different suppliers to enable development of efficient, streamlined systems. -
News Encap Drug Delivery Adds New Commercial Product to Portfolio
Encap Drug Delivery has announced the addition of a further pharmaceutical product to its portfolio of commercial products. -
News Rentschler's New Facility Wins 2012 Facility of the Year Award in Equipment Innovation
The award recognizes Rentschler for its flexible, multi-product manufacturing facility designed to minimize manufacturing costs and product cycle times.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance